Abstract
Herpes simplex encephalitis (HSE) rarely occurs in children, is not easily diagnosed, and has a poor prognosis.
Case report:
We report a pediatric case with a relapse on the 29th day despite conventional acyclovir therapy. As the relapse mechanism is not clearly understood, antiviral and immunosuppressive therapy was administered.
Conclusion:
This case underlines the importance of clinical examination and the necessity of accurate testing prior stopping antiviral treatment. A better understanding of the relapse mechanism is required in order to propose more efficient treatment.
MeSH terms
-
Acyclovir / therapeutic use
-
Anti-Anxiety Agents / administration & dosage
-
Anti-Anxiety Agents / therapeutic use
-
Anti-Inflammatory Agents / therapeutic use
-
Anticonvulsants / administration & dosage
-
Anticonvulsants / therapeutic use
-
Antiviral Agents / therapeutic use
-
Benzodiazepines*
-
Brain / diagnostic imaging
-
Child, Preschool
-
Clobazam
-
Drug Therapy, Combination
-
Encephalitis, Herpes Simplex* / diagnosis
-
Encephalitis, Herpes Simplex* / drug therapy
-
Epilepsy / drug therapy
-
Epilepsy / etiology
-
Female
-
Follow-Up Studies
-
Humans
-
Magnetic Resonance Imaging
-
Methylprednisolone Hemisuccinate / therapeutic use
-
Recurrence
-
Time Factors
-
Tomography, X-Ray Computed
-
Valproic Acid / administration & dosage
-
Valproic Acid / therapeutic use
-
Vigabatrin / administration & dosage
-
Vigabatrin / therapeutic use
Substances
-
Anti-Anxiety Agents
-
Anti-Inflammatory Agents
-
Anticonvulsants
-
Antiviral Agents
-
Benzodiazepines
-
Clobazam
-
Methylprednisolone Hemisuccinate
-
Valproic Acid
-
Vigabatrin
-
Acyclovir